Developer docs
API playgroundTry for free, no card

Search company profiles

M2I Life Sciences

Full company profile

uuid00029c6

Namestring
M2I Life Sciences
Legal namestring
MMLS SA
Company typeenum
Private
Founded yearint
2012
Descriptiontext

M2I Life Sciences is a French industrial group that operates two business divisions from four sites in France (Saint-Cloud headquarters, Lacq R&D and microencapsulation production, Parnac production and agronomic field trials, and the historic Salin-de-Giraud fine chemistry facility acquired in 2012). The Biocontrol division develops and sells pheromone-based crop protection products that use mating disruption technology to substitute for conventional chemical pesticides, available in eight formulation formats (Ball, Caps, Classic, Clip, Drop, Press, Pump, Spray) and a growing catalog of targeted products for specific pest-crop combinations across 60+ crop types, distributed in 80 countries. The Chemistry & Life Sciences division operates as a CDMO offering custom synthesis, contract manufacturing, and proprietary pharmaceutical actives and intermediates, with specialist capabilities in bromine chemistry, cyanation, sulfur and mercaptan chemistry, cyclopropane and cyclobutane chemistry, and continuous flow chemistry, producing APIs such as Pinaverium Bromide, Myrtecaïne, and Diphenhydramine Methysulfate. M2i monetizes primarily through B2B direct sales to professional agricultural users and pharmaceutical/fine chemistry clients, supplemented by a global distribution partnership with Bayer for biocontrol products and wholly-owned subsidiaries in Chile, Argentina, and Brazil; pricing is quote-based and product/contract terms are not publicly disclosed. The company holds ANSM, FDA, GMP, and ISO 9001 certifications, protects its technology with 40 patent families, and reports that its products help avoid 20,000 tonnes of pesticide use annually.

Short descriptiontext

M2I Life Sciences is a French industrial group offering pheromone-based biocontrol crop protection products and CDMO custom synthesis services for pharmaceutical and fine chemistry clients, serving professional agriculture and pharma customers across 80 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSaint-cloud, France
HQ citystring
Saint-cloud
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pheromone crop protection, biological pest control, custom synthesis services, contract development manufacturing, mating disruption technology
Industry4 codes
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAGAF
Analytical Development & QC Testing (Release/Stability/Potency)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGAKAJ
Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Services-Commercial Physical & Biological Research8731
Product category
Agricultural Biocontrol & CDMO
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Biocontrol Products
TypeOthers
Description

Sale of pheromone-based biocontrol products for crop protection, including various formulations (Ball, Caps, Classic, Clip, Drop, Press, Pump, Spray) for mating disruption

m2i-lifesciences.com
2CDMO Services
TypeProfessional Services
Description

Custom synthesis and contract manufacturing services for pharmaceutical and fine chemicals, from grams to tons scale, including GMP production and regulatory dossier preparation

m2i-lifesciences.com
3Proprietary Molecules Catalog
TypeOne Time License
Description

Sale of proprietary pharmaceutical molecules including APIs, intermediates, pheromones and specialty molecules from catalog

m2i-lifesciences.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1B2B professional agricultural products - pricing by quotation
ModelOtherBilling cadenceMulti-year contract
Notes

Products are sold to professional agricultural users (phytopharmaceutical distribution). M2i Biocontrol Approval n°9200007 for distribution of plant protection products to professional users.

m2i-lifesciences.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

M2I Life Sciences is a French industrial group operating two divisions: (1) Biocontrol — designing, manufacturing, and selling pheromone-based crop protection products that use mating disruption to replace chemical pesticides, offered in multiple formulation formats and targeting 60+ crops; and (2) Chemistry & Life Sciences (CDMO) — providing custom synthesis and contract manufacturing of pharmaceutical active ingredients, intermediates, and specialty molecules from gram to multi-ton scale, including GMP-certified production and regulatory dossier preparation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 20,000 tonnes of pesticides avoided annually through use of M2i solutions
+4 more records
Product overview1 text field

M2i Life Sciences is a French industrial group operating two main business divisions: Biocontrol and Chemistry & Life Sciences (CDMO). The Biocontrol division offers pheromone-based crop protection products using mating disruption technology, available in multiple formulation formats (Ball, Caps, Classic, Clip, Drop, Press, Pump, Spray) and targeted product lines (Frugiperda Pro, Lobesia Pro, Cydia Pro, Grapholita Pro, etc.) protecting 60+ crop types including vineyards, orchards, field crops, and forests. The Chemistry & Life Sciences division provides custom synthesis and contract manufacturing services (CDMO) for pharmaceutical active ingredients, intermediates, and specialty molecules, with proprietary products including Pinaverium Bromide, Myrtecaïne, and Diphenhydramine Methysulfate, plus specialized bromine, sulfur, cyclopropane, and cyclobutane chemistry capabilities. The company operates four sites in France (Lacq, Parnac, Saint-Cloud, Salin-de-Giraud) and three international locations (Chile, Argentina, Brazil).

Product and service10 records
1Pheromone Biocontrol Product Range (Mating Disruption Formulations)
2Tuta Pro Press
CategoryBiocontrol / Crop Protection
Description

Pheromone press formulation targeting tomato leafminer (Tuta absoluta) for professional tomato growers. Launched in 2025 in the Mauritius market.

3Crypto Pro Press
CategoryBiocontrol / Crop Protection
Description

Pheromone press formulation for vineyard crop protection, launched in 2025 in the French market as a substitute for conventional chemical pesticides.

4Lobesia Pro Clip
CategoryBiocontrol / Crop Protection
Description

Pheromone clip formulation targeting the European grapevine moth (Lobesia botrana) for vineyard protection. Launched in 2025 in the Italian market.

5Eupoecilia Pro Press
CategoryBiocontrol / Crop Protection
Description

Pheromone press formulation targeting the grape berry moth (Eupoecilia ambiguella) for vineyard protection. Launched in 2025.

6Lobesia Pro Press
CategoryBiocontrol / Crop Protection
Description

Pheromone press formulation targeting the European grapevine moth (Lobesia botrana) for vineyard protection. Technical datasheet dated 2024.

7Cydia Pro Spray
CategoryBiocontrol / Crop Protection
Description

Pheromone spray formulation targeting the codling moth (Cydia pomonella) for orchard and market gardening protection.

8CDMO Services (Custom Synthesis and Contract Manufacturing)
CategoryChemistry & Life Sciences / CDMO
Description

Custom synthesis and contract manufacturing services for pharmaceutical active ingredients, intermediates, and specialty molecules — from grams to multi-ton industrial scale. Capabilities include bromine chemistry with cyanation, sulfur/mercaptan chemistry, deprotonation by hydrides, energetic chlorinations by POCl3, cyclopropane and cyclobutane chemistry, continuous flow chemistry, GMP-certified production (ANSM, FDA), and regulatory dossier preparation. Serves pharmaceutical and fine chemistry industry clients.

9Organic Polymer Chemistry Services
CategoryChemistry & Life Sciences / CDMO
Description

Specialized polymer chemistry and formulation services offering gram-to-kilogram scale synthesis for industrial and pharmaceutical applications.

10Proprietary Pharmaceutical Molecules Catalog (APIs and Intermediates)
CategoryChemistry & Life Sciences / CDMO
Description

A catalog of proprietary pharmaceutical active ingredients and intermediates available for contract manufacturing, including Pinaverium Bromide, Trithioanisole, Myrteaïne, Myrteaïne Lauryl Sulfate, Diphenhydramine Methysulfate, and Veratole.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-01-01
Description

Bayer has partnered with M2i Group to globally distribute pheromone-based biological crop protection solutions. This strategic partnership leverages Bayer's extensive global agricultural distribution network to expand reach of M2i's sustainable biocontrol products to farmers worldwide.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

M2I Life Sciences

Agricultural Biocontrol & CDMOm2i-lifesciences.com

M2I Life Sciences is a French industrial group offering pheromone-based biocontrol crop protection products and CDMO custom synthesis services for pharmaceutical and fine chemistry clients, serving professional agriculture and pharma customers across 80 countries.

What M2I Life Sciences does

M2I Life Sciences is a French industrial group that operates two business divisions from four sites in France (Saint-Cloud headquarters, Lacq R&D and microencapsulation production, Parnac production and agronomic field trials, and the historic Salin-de-Giraud fine chemistry facility acquired in 2012). The Biocontrol division develops and sells pheromone-based crop protection products that use mating disruption technology to substitute for conventional chemical pesticides, available in eight formulation formats (Ball, Caps, Classic, Clip, Drop, Press, Pump, Spray) and a growing catalog of targeted products for specific pest-crop combinations across 60+ crop types, distributed in 80 countries. The Chemistry & Life Sciences division operates as a CDMO offering custom synthesis, contract manufacturing, and proprietary pharmaceutical actives and intermediates, with specialist capabilities in bromine chemistry, cyanation, sulfur and mercaptan chemistry, cyclopropane and cyclobutane chemistry, and continuous flow chemistry, producing APIs such as Pinaverium Bromide, Myrtecaïne, and Diphenhydramine Methysulfate. M2i monetizes primarily through B2B direct sales to professional agricultural users and pharmaceutical/fine chemistry clients, supplemented by a global distribution partnership with Bayer for biocontrol products and wholly-owned subsidiaries in Chile, Argentina, and Brazil; pricing is quote-based and product/contract terms are not publicly disclosed. The company holds ANSM, FDA, GMP, and ISO 9001 certifications, protects its technology with 40 patent families, and reports that its products help avoid 20,000 tonnes of pesticide use annually.

M2I Life Sciences firmographics

Firmographics
Name
M2I Life Sciences
Legal name
MMLS SA
Website
https://m2i-lifesciences.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
101–250 employees
Short description
M2I Life Sciences is a French industrial group offering pheromone-based biocontrol crop protection products and CDMO custom synthesis services for pharmaceutical and fine chemistry clients, serving professional agriculture and pharma customers across 80 countries.
Ownership category
akta.pro rank

M2I Life Sciences industry classification

Industry
Product category
Agricultural Biocontrol & CDMO
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAIALAD
CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAGAF
Analytical Development & QC Testing (Release/Stability/Potency)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYHLAGAKAJ
Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Pheromone crop protection
  • Biological pest control
  • Custom synthesis services
  • Contract development manufacturing
  • Mating disruption technology

Where M2I Life Sciences is headquartered

Location

Headquarters

HQ city
Saint-cloud
HQ country
France
HQ region
Europe

Offices7 records

Markets served

M2I Life Sciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Biocontrol Products: Sale of pheromone-based biocontrol products for crop protection, including various formulations (Ball, Caps, Classic, Clip, Drop, Press, Pump, Spray) for mating disruption
  2. CDMO Services: Custom synthesis and contract manufacturing services for pharmaceutical and fine chemicals, from grams to tons scale, including GMP production and regulatory dossier preparation
  3. Proprietary Molecules Catalog: Sale of proprietary pharmaceutical molecules including APIs, intermediates, pheromones and specialty molecules from catalog

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B professional agricultural products - pricing by quotation

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

M2I Life Sciences product offering

Product offering

Core offering

M2I Life Sciences is a French industrial group operating two divisions: (1) Biocontrol — designing, manufacturing, and selling pheromone-based crop protection products that use mating disruption to replace chemical pesticides, offered in multiple formulation formats and targeting 60+ crops; and (2) Chemistry & Life Sciences (CDMO) — providing custom synthesis and contract manufacturing of pharmaceutical active ingredients, intermediates, and specialty molecules from gram to multi-ton scale, including GMP-certified production and regulatory dossier preparation.

Product overview

M2i Life Sciences is a French industrial group operating two main business divisions: Biocontrol and Chemistry & Life Sciences (CDMO). The Biocontrol division offers pheromone-based crop protection products using mating disruption technology, available in multiple formulation formats (Ball, Caps, Classic, Clip, Drop, Press, Pump, Spray) and targeted product lines (Frugiperda Pro, Lobesia Pro, Cydia Pro, Grapholita Pro, etc.) protecting 60+ crop types including vineyards, orchards, field crops, and forests. The Chemistry & Life Sciences division provides custom synthesis and contract manufacturing services (CDMO) for pharmaceutical active ingredients, intermediates, and specialty molecules, with proprietary products including Pinaverium Bromide, Myrtecaïne, and Diphenhydramine Methysulfate, plus specialized bromine, sulfur, cyclopropane, and cyclobutane chemistry capabilities. The company operates four sites in France (Lacq, Parnac, Saint-Cloud, Salin-de-Giraud) and three international locations (Chile, Argentina, Brazil).

Differentiator

Problem solved

Functional benefit

Products and services

  • Pheromone Biocontrol Product Range (Mating Disruption Formulations)
  • Tuta Pro Press Pheromone press formulation targeting tomato leafminer (Tuta absoluta) for professional tomato growers. Launched in 2025 in the Mauritius market.
  • Crypto Pro Press Pheromone press formulation for vineyard crop protection, launched in 2025 in the French market as a substitute for conventional chemical pesticides.
  • Lobesia Pro Clip Pheromone clip formulation targeting the European grapevine moth (Lobesia botrana) for vineyard protection. Launched in 2025 in the Italian market.
  • Eupoecilia Pro Press Pheromone press formulation targeting the grape berry moth (Eupoecilia ambiguella) for vineyard protection. Launched in 2025.
  • Lobesia Pro Press Pheromone press formulation targeting the European grapevine moth (Lobesia botrana) for vineyard protection. Technical datasheet dated 2024.
  • Cydia Pro Spray Pheromone spray formulation targeting the codling moth (Cydia pomonella) for orchard and market gardening protection.
  • CDMO Services (Custom Synthesis and Contract Manufacturing) Custom synthesis and contract manufacturing services for pharmaceutical active ingredients, intermediates, and specialty molecules — from grams to multi-ton industrial scale. Capabilities include bromine chemistry with cyanation, sulfur/mercaptan chemistry, deprotonation by hydrides, energetic chlorinations by POCl3, cyclopropane and cyclobutane chemistry, continuous flow chemistry, GMP-certified production (ANSM, FDA), and regulatory dossier preparation. Serves pharmaceutical and fine chemistry industry clients.
  • Organic Polymer Chemistry Services Specialized polymer chemistry and formulation services offering gram-to-kilogram scale synthesis for industrial and pharmaceutical applications.
  • Proprietary Pharmaceutical Molecules Catalog (APIs and Intermediates) A catalog of proprietary pharmaceutical active ingredients and intermediates available for contract manufacturing, including Pinaverium Bromide, Trithioanisole, Myrteaïne, Myrteaïne Lauryl Sulfate, Diphenhydramine Methysulfate, and Veratole.

Quantifiable outcome

  • 20,000 tonnes of pesticides avoided annually through use of M2i solutions
  • +4 more outcomes

Companies that use M2I Life Sciences

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles2 records

M2I Life Sciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

M2I Life Sciences partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • BayercoreChannel Partner/ Reseller/ Distributor · 1 January 2025Bayer has partnered with M2i Group to globally distribute pheromone-based biological crop protection solutions. This strategic partnership leverages Bayer's extensive global agricultural distribution network to expand reach of M2i's sustainable biocontrol products to farmers worldwide.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

M2I Life Sciences competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

M2I Life Sciences social profiles

Digital presence

M2I Life Sciences compliance and trust

Trust signal

Compliance4 records

M2I Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

M2I Life Sciences leadership team

Management profile

Number of profiles

Profiles1 record

M2I Life Sciences subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

M2I Life Sciences funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M2I Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about M2I Life Sciences

What does M2I Life Sciences do?

M2I Life Sciences is a French industrial group operating two divisions: (1) Biocontrol — designing, manufacturing, and selling pheromone-based crop protection products that use mating disruption to replace chemical pesticides, offered in multiple formulation formats and targeting 60+ crops; and (2) Chemistry & Life Sciences (CDMO) — providing custom synthesis and contract manufacturing of pharmaceutical active ingredients, intermediates, and specialty molecules from gram to multi-ton scale, including GMP-certified production and regulatory dossier preparation.

Is M2I Life Sciences a public or private company?

M2I Life Sciences is a private company. It is classified as venture growth investor backed and is currently operating.

When was M2I Life Sciences founded?

M2I Life Sciences was founded in 2012. It employs 101 to 250 people.

Where is M2I Life Sciences based?

M2I Life Sciences is headquartered in Saint-cloud, France, in the Europe region.

How does M2I Life Sciences make money?

Three revenue lines are on record. Biocontrol Products are the primary driver. The others are CDMO Services and proprietary Molecules Catalog.

Does M2I Life Sciences have an API?

No public API is recorded for M2I Life Sciences.

What industry is M2I Life Sciences in?

M2I Life Sciences's product category is Agricultural Biocontrol & CDMO. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAIALAD, CMC & Pharmaceutical Development (Formulation/Process/Analytical Development). Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogSyngenta Crop Protection Launches M2i’s Pheromone-Based Technology, EXPLOYO™ Vit, to Support Wine Growers in FranceSyngenta Crop Protection and M2i launched EXPLOYO Vit, a pheromone-based sprayable solution for French wine growers to control vine moth and botrytis. The organic-certified product targets the vine moth Lobesia botrana, which infects grapes with a deadly fungus. It will roll out in Spain, Portugal, and Greece within 12 months.PrwebCorteva Agriscience building new Biologicals portfolio; selects M2i for first global agreementsCorteva Agriscience and M2i announced multi-year global agreements for research, development, and commercialization of pheromone-based insect control solutions. The collaboration will combine M2i's semiochemical portfolio with Corteva's technologies to develop novel pest-control options. These are the first agreements for Corteva's new global Biologicals portfolio.GlobalaginvestingADM Capital Leads EUR60M Round for Biological Crop Protection Startup M2i Life SciencesADM Capital led a EUR60 million funding round for M2i Life Sciences, a French biological crop protection startup producing pheromones. The capital will expand its product range and geographic presence, with the plant protection market projected to reach $26 billion by 2030.FinSMEsM2i Life Sciences Raises €12M in FundingM2i Life Sciences raised €12M from Idinvest Partners. The funds will support the approval process for its Biocontrol products, R&D, and international development. The company, founded in 2013, employs 110 people and holds 12 patent families.